Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody

Tumor Biology

Volumn 20, Issue 3, 1999, Pages 139-146

  Shigeoka, Hironori ^a,c   Karsten, Uwe ^b   Okuno, Kiyotaka ^a   Yasutomi, Masayuki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c NONE   (Japan)

Author keywords

Colon 26; Liver metastasis; Neuraminidase; Thomsen Friedenreich antigen

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; INTEGRIN; LIGAND; MONOCLONAL ANTIBODY; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; COLORECTAL CARCINOMA; FEMALE; KUPFFER CELL; LIVER CELL; LIVER METASTASIS; LIVER SINUSOID; METASTASIS INHIBITION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR CELL;

EID: 0032946962     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030056     Document Type: Article

References (28)

1. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1993;56:5309-5318.
2. Weiss L: Nueraminidase, sialic acid and cell interactions. J Natl Cancer Inst 1973;50:3-19.
3. Sinha BK, Goldenberg GJ: The effect of trypsin and neuraminidase on the circulation and organ distribution of tumor cells. Cancer 1974; 34:1956-1961.
4. Schlepper-Schafer J, Friedrich E, Kolb HA: Galactosyl specific receptor on liver cells: Binding site for tumor cells. Eur J Cell Biol 1981;25: 95-102.
5. Beuth J, Ko HL, Oette K, Pulverer G, Roszkowski K, Uhlenbruck G: Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol 1987;113:51-55.
6. Springer GF, Cheingsong-Popov R, Schirrmacher V, Desai PR, Tegtmeyer H: Proposed molecular basis of murine tumor cell-hepatocyte interaction. J Biol Chem 1983;258: 5702-5706.
7. Yeatman TJ, Bland KI, Copeland EM, Kimura AK: Tumor cell-surface galactose correlates with the degree of colorectal liver metastasis. J Surg Res 1989;46:567-571.
8. Okuno K, Shirayama Y, Ohnishi H, Yamamoto K, Ozaki M, Hirohata T, Nakajima I, Yasutomi M: A successful liver metastasis model in mice with neuraminidase treated Colon 26. Surg Today 1993;23:795-799.
9. Ashwell G, Harford J: Carbohydrate-specific receptors of liver. Annu Rev Biochem 1982;51:531-554.
10. Springer GF: T and Tn, general carcinoma autoantigens. Science 1984; 224:1198-1206.
11. Coon JS, Weinstein RS, Summers JL: Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 1982;77:692-699.
12. Lehman TP, Cooper HS, Mulholland SG: Peanuts lectin binding sites in transitional cell carcinoma of the urinary bladder. Cancer 1984;53: 272-277.
13. Sotozono M, Okada Y, Tsuji T: The Thomsen-Friedenreich antigen-related carbohydrate antigens in human gastric intestinal metaplasia and cancer. J Histochem Cytochem 1994;42:1575-1584.
14. Chung YS, Yamashita Y, Kato Y, Nakata B, Sawada T, Sowa M: Prognostic significance of T antigen expression in patients with gastric carcinoma. Cancer 1996;77:1768-1773.
15. Springer GF: Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 1997;75:594-602.
16. Barr N, Taylor CR. Young T, Springer GF: Are pancarcinoma T and Tn differentiation antigens? Cancer 1989;64:834-841.
17. Cao Y, Stosiek P, Springer GF, Karsten U: Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: A systematic and comparative study. Histochem Cell Biol 1996;106:197-207.
18. Cao Y, Karsten UR, Liebrich W, Haensch W, Springer GF, Schlag PM: Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. Cancer 1995;76:1700-1708.
19. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG: A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Hybridoma 1995;14:37-44.
20. Welch JP, Donaldson GA: Clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496-502.
21. Bengmark S, Hafström L: The natural history of primary and secondary malignant tumors of the liver. Cancer 1969;23:198-202.
22. Nielsen J, Balslev I, Jensen HE: Carcinoma of the colon with liver metastasis. Acta Chir Scand 1971;137: 463-465.
23. x ligands of definite structures as inhibitors of E-selectin-mediated cell adhesion. Glycobiology 1998;8: 311-319.
24. Cao Y, Schlag PM, Karsten U: Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotypes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: Apolar localization corresponds to malignant transformation. Virchows Arch 1997;431:159-166.
25. Kawakami H, Ito M, Miura Y, Hirano H: Expression of Lewis(x) sugar structure in the liver metastasis of mouse colon carcinoma (colon 26) cells. Clin Exp Metastasis 1994;12: 129-133.
26. Hida J, Matsuda T, Kitaoka M, Machidera N, Kubo R, Yasutomi M: The role of basement membrane in colorectal cancer invasion and liver metastasis. Cancer 1994;74:592-598.
27. Petrick AT, Meterissian S, Steele G, Thomas P: Desialylation of metastatic human colorectal carcinoma cells facilitates binding to Kupffer cells. Clin Exp Metastasis 1994;12: 108-116.
28. Philips NC: Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity. Cancer Metastasis Rev 1989;8:231-252.